What technology area does this patent fall under?

Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.

When was this patent published?

Publication date Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.

What related patents are in patentsdb?

We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).

Mutant pore

US11104709B2 · US · B2

Patent metadata
Field	Value
Publication number	US-11104709-B2
Application number	US-201716091746-A
Country	US
Kind code	B2
Filing date	Apr 6, 2017
Priority date	Apr 6, 2016
Publication date	Aug 31, 2021
Grant date	Aug 31, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

Title
What the patent document calls the invention.
Abstract
A short plain-language summary of the technical disclosure.
Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
Key dates
Filing, priority, publication, and grant dates set the timeline.
First independent claim
The legal scope of protection — read this for what is actually claimed.
CPC / IPC classifications
Technology tags used to group this patent with similar filings.
Citations and related patents
Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to mutant forms of lysenin. The invention also relates to analyte characterisation using the mutant forms of lysenin.

First claim

Opening claim text (preview).

The invention claimed is: 1. A mutant lysenin monomer comprising a variant of the amino acid sequence set forth in SEQ ID NO: 2, wherein the variant comprises one of the following combinations of amino acid substitutions: E94D/K99Q/T106K; E94D/T93K/T106K; E94D/T91K/T106K; H83K/E94D/T106K; E94Q/Y96D/T106K; K45D/E94K/T106K; K45R/E94D/T106K; E94D/S98K/K99L/T106K; K37N/E94D/T106K; K37W/E94D/T106K; K37S/E94D/T106K; K45N/E94N/T106K; K37Q/E94D/E102N/T106K; K37S/E94D/E102S/T106K; K37S/E94D/T104K/T106K; K45Q/E94Q/T106K; K45T/V47K/E94D/T106K; V47S/E94D/T106K; T51K/E94D/T106K; K45Y/S49K/E94D/T106K; S49L/E94D/T106K; K45R/T106K; V47K/E94D/T106K; G43K/E94D/T106K; V88I/M90A/E94D/T106K; V47N/V88T/E94D/T106K; K45N/S49K/E94N/E92D/T106K; K45N/V47K/E92D/E94N/T106K; or E94D/K99Q/T106K.

Assignees

Oxford Nanopore Tech Ltd

Inventors

Classifications

C07K14/43504
from invertebrates · CPC title
C12Q1/6869Primary
Methods for sequencing · CPC title
C12Q2563/116
electrical properties of nucleic acids, e.g. impedance, conductivity or resistance · CPC title
C12Q1/68
involving nucleic acids · CPC title
C07K14/43536Primary
from worms · CPC title

Patent family

Related publications grouped by family.

View patent family 58672620

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11104709B2 cover?: The invention relates to mutant forms of lysenin. The invention also relates to analyte characterisation using the mutant forms of lysenin.
Who is the assignee on this patent?: Oxford Nanopore Tech Ltd
What technology area does this patent fall under?: Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?: Publication date Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?: We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).